Search

Search Constraints

You searched for: Author/Creator Brockbank, Elly

Search Results

1. 2022-RA-1310-ESGO Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer. (20th October 2022)

2. 2022-RA-1443-ESGO Patient decision aids in genetic testing for women with ovarian cancer. (20th October 2022)

4. Concise Reporting of Benign Endometrial Biopsies is an Acceptable Alternative to Descriptive Reporting. (January 2022)

6. Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results. (25th January 2019)

7. Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results. Issue 2 (February 2019)

8. Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative). Issue 12 (15th November 2022)

10. Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated Into Routine Care or Offered in the Context of a Clinical Trial?. Issue 1 (1st January 2016)